Prostate Grand Rounds – Gloversville, NY
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This live activity will cover the treatment and management of patients with refractory metastatic colorectal cancer (CRC).
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This program will review current and emerging therapies for the management of HER2-positive gastric cancer.
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
This case-based live activity will cover the treatment and management of patients with hemophilia A
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).